Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Neuronetics Inc (NQ: STIM ) 0.8600 -0.0600 (-6.52%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Neuronetics Inc < Previous 1 2 3 4 5 6 Next > Top 5 Health Care Stocks That May Plunge In March March 28, 2024 As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. Via Benzinga Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 25, 2024 Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session March 25, 2024 Via Benzinga Earnings Outlook For Neuronetics March 04, 2024 Via Benzinga NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression March 25, 2024 NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and older From Neuronetics Via GlobeNewswire Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network March 07, 2024 From Neuronetics Via GlobeNewswire Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System February 12, 2024 Advancements provide workflow efficiencies for NeuroStar® TMS providers From Neuronetics Via GlobeNewswire Earnings Scheduled For March 5, 2024 March 05, 2024 Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. Via Benzinga NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update February 06, 2024 Criteria Change Reduces Requirements for Treatment Accessibility From Neuronetics Via GlobeNewswire Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory December 18, 2023 New accessory for NeuroStar TMS reduces patient setup steps and improves efficiency for providers From Neuronetics Via GlobeNewswire NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements November 13, 2023 New updates designed to advance practice efficiency and patient outcomes From Neuronetics Via GlobeNewswire NeuroStar TMS Receives Expanded Regulatory Approval in Japan December 04, 2023 Technological advances reduce time and increase efficiency for MDD treatment From Neuronetics Via GlobeNewswire Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage November 09, 2023 Policy Updates from Magellan and Two Additional Payors Increase Access for 3.2 Million Covered Lives From Neuronetics Via GlobeNewswire Earnings Scheduled For November 7, 2023 November 07, 2023 Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. Via Benzinga Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes October 16, 2023 Findings confirm strong correlation between the number of TMS treatment sessions completed and improvement in MDD From Neuronetics Via GlobeNewswire Stocks That Hit 52-Week Lows On Thursday September 21, 2023 During the session on Thursday, 461 stocks hit new 52-week lows. Via Benzinga In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression September 12, 2023 Portal provides resources to raise awareness around mental health and suicide prevention From Neuronetics Via GlobeNewswire Stocks That Hit 52-Week Lows On Thursday September 07, 2023 On Thursday, 283 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday August 22, 2023 On Tuesday, 210 companies reached new 52-week lows. Via Benzinga NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards August 21, 2023 Award Acknowledges Excellence in Digital Marketing Efforts From Neuronetics Via GlobeNewswire Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform August 14, 2023 New automated features elevate the standard of care for NeuroStar® Advanced Therapy practices From Neuronetics Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session August 11, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Friday August 11, 2023 During the Friday's sesion, 157 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Thursday August 10, 2023 On Thursday, 128 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday August 04, 2023 On Friday, 73 companies reached new 52-week lows. Via Benzinga Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans July 19, 2023 Policy Updates Impact Nationwide Commercial Plans for 16.8 Million Covered Lives From Neuronetics Via GlobeNewswire Neuronetics' NeuroStar Gets Regulatory Clearance In South Korea July 17, 2023 Neuronetics, Inc. (NASDAQ: STIM) announced that the Ministry of Food and Drug Safety (MFDS) in South Korea has approved multiple features of NeuroStar TMS (transcranial magnetic stimulation) for Via Benzinga NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player July 11, 2023 Award Recognizes Efforts to Raise Awareness Around Non-Drug Depression Treatment From Neuronetics Via GlobeNewswire NeuroStar Achieves Milestone Regulatory Clearance in South Korea July 17, 2023 First International Approval for Expanded Indication and Certification for MT Cap and D-Tect™ Technologies From Neuronetics Via GlobeNewswire Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy June 12, 2023 The Company expands technology for patients with obsessive-compulsive disorder From Neuronetics Via GlobeNewswire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.